Press Release: Cellphire : Cellphire Announces Orphan Drug Designation of Thrombosomes for Treatment of Acute Radiation Syndrome

ROCKVILLE, Md., May 14, 2020 /PRNewswire/ -- Cellphire, the global leader in long-term stabilization and storage of platelets, announced today that the U.S. Food and Drug Administration (FDA) has granted an orphan drug designation for its platelet-based freeze-dried hemostatic,...